CRISPR-genome editing: Revolutionizing beneficial Bacteria and Fungi for sustainable agriculture

Read full text
Authors: Gabriel Moura Mascarin, Maicon Sérgio Nascimento dos Santos, Márcio Vinícius de Carvalho Barros Côrtes
Cited by: 1
References: 99

Abstract

The manipulation of beneficial microorganisms transcends conventional biotechnology to become the biogenic infrastructure of a resilient agriculture. Although the CRISPR/Cas9 system has established itself as a superior genome editing tool, mainly due to its precision, simplicity, and cost-effectiveness, its full translation into agromicrobial ecosystems faces critical biological and technical bottlenecks. This review rigorously evaluates the implementation of CRISPR systems in fundamental taxa, such as Trichoderma , Bacillus , and diazotrophic bacteria, confronting systemic challenges that include the cytotoxicity of Cas9 overexpression, the frequency of off-target mutations, and structural instability in organisms. Additionally, Brazilian bioinnovation has subverted these limitations through the development of marker-free genomic architectures and the optimization of virulence factors in biocontrol agents, establishing a new paradigm of microbial engineering. The evolution of these tools requires not only the improvement of delivery methods, currently inefficient in several species, but also a radical modernization of regulatory frameworks. This paper discusses how the legal classification of these organisms under Brazilian biosafety will shape the future of intellectual property (IP) and the commercial viability of next-generation inoculants. Ultimately, it proposes that overcoming these technical obstacles and changing public perception are imperative for genome editing to catalyze a sustainable revolution in global agricultural productivity.

Fields of Study & Subjects

CRISPR and Genetic Engineering Genetically Modified Organisms Research Biotechnology and Related Fields

Publication details

Journal / source
Current Research in Biotechnology
Publisher
Elsevier BV
Volume
12
Pages
100404–100404
Publication date
1 January 2026
Language
EN